251 related articles for article (PubMed ID: 25609016)
1. Metabolomics-derived prostate cancer biomarkers: fact or fiction?
Kumar D; Gupta A; Mandhani A; Sankhwar SN
J Proteome Res; 2015 Mar; 14(3):1455-64. PubMed ID: 25609016
[TBL] [Abstract][Full Text] [Related]
2. Low- and high-grade bladder cancer determination via human serum-based metabolomics approach.
Bansal N; Gupta A; Mitash N; Shakya PS; Mandhani A; Mahdi AA; Sankhwar SN; Mandal SK
J Proteome Res; 2013 Dec; 12(12):5839-50. PubMed ID: 24219689
[TBL] [Abstract][Full Text] [Related]
3. NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
Kumar D; Gupta A; Mandhani A; Sankhwar SN
Prostate; 2016 Sep; 76(12):1106-19. PubMed ID: 27197810
[TBL] [Abstract][Full Text] [Related]
4. ¹H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma.
Gupta A; Gupta S; Mahdi AA
Clin Chim Acta; 2015 Feb; 441():47-55. PubMed ID: 25499120
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
6. 1H NMR-derived metabolomics of filtered serum of myocardial ischemia in unstable angina patients.
Ameta K; Gupta A; Ameta D; Sethi R; Kumar D; Ahmad I; Mahdi AA
Clin Chim Acta; 2016 May; 456():56-62. PubMed ID: 26926967
[TBL] [Abstract][Full Text] [Related]
7. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
8. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
10. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
11. Seminal plasma metabolomics reveals lysine and serine dysregulation as unique features distinguishing between prostate cancer tumors of Gleason grades 6 and 7.
Falegan OS; Jarvi K; Vogel HJ; Hyndman ME
Prostate; 2021 Aug; 81(11):713-720. PubMed ID: 34097313
[TBL] [Abstract][Full Text] [Related]
12. Essential hypertension: A filtered serum based metabolomics study.
Ameta K; Gupta A; Kumar S; Sethi R; Kumar D; Mahdi AA
Sci Rep; 2017 May; 7(1):2153. PubMed ID: 28526818
[TBL] [Abstract][Full Text] [Related]
13. Novel Metabolic Signatures of Prostate Cancer Revealed by
Yang B; Zhang C; Cheng S; Li G; Griebel J; Neuhaus J
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33498542
[TBL] [Abstract][Full Text] [Related]
14. Low- and high-grade bladder cancer appraisal via serum-based proteomics approach.
Bansal N; Gupta A; Sankhwar SN; Mahdi AA
Clin Chim Acta; 2014 Sep; 436():97-103. PubMed ID: 24875752
[TBL] [Abstract][Full Text] [Related]
15. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
Ouyang X; Dai Y; Wen JL; Wang LX
Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
[TBL] [Abstract][Full Text] [Related]
16. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
[TBL] [Abstract][Full Text] [Related]
17. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolic biomarkers for discriminating individuals with alcohol use disorders from social drinkers and alcohol-naive subjects.
Mostafa H; Amin AM; Teh CH; Murugaiyah VA; Arif NH; Ibrahim B
J Subst Abuse Treat; 2017 Jun; 77():1-5. PubMed ID: 28476260
[TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer.
Nizioł J; Ossoliński K; Tripet BP; Copié V; Arendowski A; Ruman T
Anal Bioanal Chem; 2020 Sep; 412(23):5827-5841. PubMed ID: 32661677
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
